Introducing RpsA point mutations 438A and D123A into the chromosome of mycobacterium tuberculosis confirms their role in causing resistance to pyrazinamide

Wanliang Shi, Peng Cui, Hongxia Niu, Shuo Zhang, Tone Tønjum, Bingdong Zhu, Ying Zhang

Research output: Contribution to journalArticle

Abstract

Pyrazinamide (PZA) is a unique frontline drug for shortening tuberculosis (TB) treatment, but its mechanisms of action are elusive. We previously found one PZA-resistant strain that harbors an alanine deletion at position 438 (Δ438A) in RpsA, a target of PZA associated with PZA resistance, but its role in causing PZA resistance has been inconclusive. Here, we introduced the RpsA Δ438A mutation along with the D123A mutation into the Mycobacterium tuberculosis chromosome and demonstrated that these RspA mutations are indeed responsible for PZA resistance.

Original languageEnglish (US)
Article numbere02681-18
JournalAntimicrobial agents and chemotherapy
Volume63
Issue number6
DOIs
StatePublished - Jun 1 2019

Fingerprint

Pyrazinamide
Mycobacterium tuberculosis
Point Mutation
Chromosomes
Mutation
Alanine
Tuberculosis
Pharmaceutical Preparations

Keywords

  • Drug resistance mechanisms
  • Mycobacterium tuberculosis
  • Pyrazinamide
  • RpsA

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Introducing RpsA point mutations 438A and D123A into the chromosome of mycobacterium tuberculosis confirms their role in causing resistance to pyrazinamide. / Shi, Wanliang; Cui, Peng; Niu, Hongxia; Zhang, Shuo; Tønjum, Tone; Zhu, Bingdong; Zhang, Ying.

In: Antimicrobial agents and chemotherapy, Vol. 63, No. 6, e02681-18, 01.06.2019.

Research output: Contribution to journalArticle

@article{1c7375fd9fa64f97beb1761fa5cdea72,
title = "Introducing RpsA point mutations 438A and D123A into the chromosome of mycobacterium tuberculosis confirms their role in causing resistance to pyrazinamide",
abstract = "Pyrazinamide (PZA) is a unique frontline drug for shortening tuberculosis (TB) treatment, but its mechanisms of action are elusive. We previously found one PZA-resistant strain that harbors an alanine deletion at position 438 (Δ438A) in RpsA, a target of PZA associated with PZA resistance, but its role in causing PZA resistance has been inconclusive. Here, we introduced the RpsA Δ438A mutation along with the D123A mutation into the Mycobacterium tuberculosis chromosome and demonstrated that these RspA mutations are indeed responsible for PZA resistance.",
keywords = "Drug resistance mechanisms, Mycobacterium tuberculosis, Pyrazinamide, RpsA",
author = "Wanliang Shi and Peng Cui and Hongxia Niu and Shuo Zhang and Tone T{\o}njum and Bingdong Zhu and Ying Zhang",
year = "2019",
month = "6",
day = "1",
doi = "10.1128/AAC.02681-18",
language = "English (US)",
volume = "63",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Introducing RpsA point mutations 438A and D123A into the chromosome of mycobacterium tuberculosis confirms their role in causing resistance to pyrazinamide

AU - Shi, Wanliang

AU - Cui, Peng

AU - Niu, Hongxia

AU - Zhang, Shuo

AU - Tønjum, Tone

AU - Zhu, Bingdong

AU - Zhang, Ying

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Pyrazinamide (PZA) is a unique frontline drug for shortening tuberculosis (TB) treatment, but its mechanisms of action are elusive. We previously found one PZA-resistant strain that harbors an alanine deletion at position 438 (Δ438A) in RpsA, a target of PZA associated with PZA resistance, but its role in causing PZA resistance has been inconclusive. Here, we introduced the RpsA Δ438A mutation along with the D123A mutation into the Mycobacterium tuberculosis chromosome and demonstrated that these RspA mutations are indeed responsible for PZA resistance.

AB - Pyrazinamide (PZA) is a unique frontline drug for shortening tuberculosis (TB) treatment, but its mechanisms of action are elusive. We previously found one PZA-resistant strain that harbors an alanine deletion at position 438 (Δ438A) in RpsA, a target of PZA associated with PZA resistance, but its role in causing PZA resistance has been inconclusive. Here, we introduced the RpsA Δ438A mutation along with the D123A mutation into the Mycobacterium tuberculosis chromosome and demonstrated that these RspA mutations are indeed responsible for PZA resistance.

KW - Drug resistance mechanisms

KW - Mycobacterium tuberculosis

KW - Pyrazinamide

KW - RpsA

UR - http://www.scopus.com/inward/record.url?scp=85066443008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066443008&partnerID=8YFLogxK

U2 - 10.1128/AAC.02681-18

DO - 10.1128/AAC.02681-18

M3 - Article

VL - 63

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 6

M1 - e02681-18

ER -